Rohto Pharmaceutical Joins 'ASAGI Labs Longevity Consortium'
NQ Score
49/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Rohto Pharmaceutical has joined the 'ASAGI Labs Longevity Consortium' established by ASAGI Labs. By leveraging its expertise in cell research and consumer touchpoints, the company aims to extend healthy life expectancy and create new longevity solutions.
AI Analysis
Frequently Asked Questions
- Q: What is Rohto's approach to longevity?
- A: Leveraging cell research knowledge to implement solutions that maximize health.